H-FLPSDFFPSI^-OH

Ref. 3D-PP41135

Produktinformation

• Name: H-FLPSDFFPSI^-OH

Beschreibung

Peptide H-FLPSDFFPSI^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLPSDFFPSI^-OH include the following: Identification of a Novel CD8+ T Cell Epitope Derived from Cancer-Testis Antigen MAGE-4 in Oesophageal Carcinoma ZY Wu, YF Gao, YH Wu, W Liu , M Sun - Scandinavian , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-3083.2011.02606.x Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus YH Huang , MH Tao , C Hu - Journal of general , 2004 - microbiologyresearch.orghttps://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.80183-0 Next Generation Sequencing-Based Identification of T-Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma Y Ma, J Ou, T Lin, L Chen, J Chen - Hepatology , 2021 - Wiley Online Libraryhttps://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1697 Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant PS Sung , DJ Park , JH Kim, JW Han , EB Lee - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2019.01319/full Identification and characterization of HBV core CTL epitopes in Indonesian samples NKD Nursanty - 2013 - bridges.monash.eduhttps://bridges.monash.edu/articles/thesis/Identification_and_characterization_of_HBV_core_CTL_epitopes_in_Indonesian_samples/4633777 Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell M Shi, S Qian, WW Chen, H Zhang - Clinical & , 2007 - academic.oup.comhttps://academic.oup.com/cei/article-abstract/147/2/277/6457198 Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection M Shi, J Fu, F Shi , B Zhang, Z Tang, L Jin , Z Fan - Clinical , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661609000710 The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. LHG Liu HengGui, CWW Chen WeiWei - 2007 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20083024118 Presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients L Yang, S Ma, X Hu, L Xiao, Z Wang, Y Li - Journal of medical , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.21944 A deficient translocation of CD3ζ, ZAP-70 and Grb2 to lipid raft, as a hallmark of defective adaptive immune response during chronic hepatitis B infection L Barboza , S Salmen , G Teran-Angel , DL Peterson - Cellular , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874913000932 The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope HG Liu, W Chen, ZP Fan, H Yang, M Shi, Z Zhang - Clinical , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661607012776 Recombinant heat shock protein 65 carrying PADRE and HBV epitopes activates dendritic cells and elicits HBV-specific CTL responses H Wang, X Su, P Zhang, J Liang, H Wei, M Wan, X Wu - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X11000053 Response to: Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB' D Wu, D Huang, W Yan, Q Ning - Journal of Hepatology, 2023 - journal-of-hepatology.euhttps://www.journal-of-hepatology.eu/article/S0168-8278(23)05043-2/abstract Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB' A Bertoletti , N Le Bert , AT Tan , C Boni - Journal of , 2023 - journal-of-hepatology.euhttps://www.journal-of-hepatology.eu/article/S0168-8278(23)00408-7/abstract

• Marke: Biosynth